SS12: Clinical Science: Special Reports

Updated:Nov 12,2013
ra web masthead-SS12 
 

Clinical Science: Special Reports

Monday, Nov. 5, 2012
CS.01: Clinical Science: Special Reports: Prevention and Treatment of Ischemic Heart Disease: Novel Approaches
ss12_stefan nidorf
Stefan Mark Nidorf
Heart Care WA
Perth, Australia

Low Dose Colchicine for Secondary Prevention of Cardiovascular Disease [LoDoCo]: A Randomized Controlled Trial
Presenter Slides  |  Presentation Audio  |  Discussant Audio 

 ss12_wei jiang
Wei Jiang
Duke University Medical Center
Durham, NC

Results of the Responses of Myocardial Ischemia to Escitalopram Treatment Trial
Presentation Slides  |  Presentation Audio  |  Discussant Audio  

 ss12_kristin newby
L Kristin Newby
 Duke University Medical Center
Durham, NC

Safety and Efficacy of Losmapimod in Non-ST-Segment Elevation Acute Myocardial Infarction: Results of the SOLSTICE Phase 2 Randomized Trial
Presentation Slides  |  Presentation Audio  |  Discussant Audio

 

ss12_vasillos papademetriou
Vasilios Papademetriou
VA Med Ctr, Washington, DC 

EnligHTN™ I, First-in-man Multi-center Study of a Novel Multi-electrode Renal Denervation Catheter in Patients with Drug-Resistant Hypertension
Presentation Audio  |  Discussant Audio  

 

Back to Top


CS.02: Clinical Science: Special Reports: New Insights into Management of Common Cardiovascular Disorders
 David G Jones
Royal Brompton & Harefield, Imperial Coll, London, United Kingdom
 A Randomised Trial to Assess Catheter Ablation versus Rate Control in the Management of Persistent Atrial Fibrillation in Chronic Heart Failure
Xue Zhao
Shanghai Changzheng Hosp,Second Military Medical Univ, Shanghai, China
 Pulmonary Antrum Radial-linear Ablation of Paroxysmal Atrial Fibrillation: First-in-human Multicenter Clinical Outcome
 Hung-Fat Tse
The Univ of Hong King, Hong Kong, Hong Kong
 "Prospective Randomized Study to Assess the Efficacy of Site and Rate of Atrial Pacing on Long-term Progression of Atrial Fibrillation in Sick Sinus Syndrome- Septal Pacing for Atrial Fibrillation Suppression Evaluation [SAFE] Study"
 Marc Semigran
Massachusetts General Hosp Heart Ctr, Boston, MA
 Left Ventricular Systolic Dysfunction Associated With Pulmonary Hypertension Riociguat Trial (LEPHT)
Mads J Andersen
Rigshospitalet, København Ø, Denmark
"Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction in Patients with Preserved Ejection Fraction - A Prospective, Double Blinded Placebo-controlled Randomized Trial (SIDAMI)"
Back to Top


Tuesday, Nov. 6, 2012
CS.03: Clinical Science: Special Reports: Emerging Therapeutics for Diabetes and Dyslipidemia
 SS12_Rosenstock
Julio Rosenstock
Dallas Diabetes and Endocrine Ctr., Dallas, TX
 Impact of LX4211, a Dual Inhibitor of Sodium Glucose Transporter 1 and 2 on Cardiovascular Risk Factors in Type 2 Diabetes
SS12_Giugliano
  Robert P Guigliano
Brigham and Womens Hosp, Boston, MA
 LAPLACE-TIMI 57 Primary Results
SS12_Koren
  Michael J. Koren
Jacksonville Ctr for Clinical Res, Jacksonville, FL
 Efficacy and Safety of a Fully Human Monoclonal Antibody Against PCSK9 as Monotherapy for Hypercholesterolemia: Results from the MENDEL Study, a Global Phase 2 Trial of AMG 145
 SS12_Desai
 Nihar R Desai
TIMI Study Group, Div of Cardiovascular Med, Brigham and Women's Hosp, Boston, MA
 AMG 145, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin type 9 (PCSK9), Facilitates Achievement of NCEP LDL-Cholesterol Goals in High-Risk Patients
Back to Top


Wednesday, Nov. 7, 2012
CS.04: Clinical Science: Special Reports: Valvular Heart Disease, PAD, Atrial Fibrillation: International Perspectives
 K.M. John Chan
Imperial Coll London, London, United Kingdom
Mitral Valve Annuloplasty Plus CABG versus CABG Only in Moderate Functional Ischemic Mitral Regurgitation: Final Results of the Randomized Ischemic Mitral Evaluation (RIME) Trial
 Masato Nakamura
Toho Univ, Ohashi medical Ctr, Tokyo, Japan
EndOVascular Treatment for Infra-inguinal Vessel, in Patients With Critical Limb Sichemia (olive) Registry in Japan
 Mohammad Zubaid
Faculty of Med, Kuwait Univ, Kuwait City, Kuwait
Management and One Year Outcome of Atrial Fibrillation in Middle Eastern Cohort Enrolled in the Observational Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)
 Steven Swiryn
Northwestern Univ, Chicago, IL
Clinical Implications of Device-Detected Atrial Tachyarrhythmias: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the Cardiac Rhythm Management Device Population (RATE)
Presentation Slides
 
Ajay K Kakkar
Thrombosis Res Inst, London, United Kingdom
Antithrombotic Treatments and Associated Outcomes in Patients with Atrial Fibrillation: The Global Anticoagulant Registry in the FIELD (GARFIELD)
Stuart J Connolly
McMaster Univ, Hamilton, ON, Canada
Randomized Comparison of the Effects of Two Doses of Dabigatran Etexilate on Clinical Outcomes Over 4.3 Years: Results of the Rely-able Double-blind Randomized Trial
  
Back to Top


Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Network with over 31,000 Heart and Stroke Professionals

  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org

Science News: Why I Subscribe

  • ss11_sn_gordontomaselli
  • ss11_sn_RobertHarrington
  • ss11_sn_elliottantman
  • ss11_sn_mikhailkosiborod

Why I Subscribe to Science News: Mikhail Kosiborod, MD, FAHA

Become A Member

Become a professional member of the American Heart Association/American Stroke Association.

Join or renew your AHA/ASA Professional Membership
to qualify for members-only awards, and:

• Affiliate with one of 16 Scientific Councils.
• Save on AHA/ASA Scientific Sessions.
• Save on print publications.
• Apply for research funding and not pay a fee
• Enjoy many more membership benefits.

Promo code: WDJ008ZZ